Document is current
Any future updates will be listed below
-
Authors
Vahid, Milad R.
Brown, Erin L. https://orcid.org/0000-0002-0004-3487
Steen, Chloé B. https://orcid.org/0000-0001-7290-7128
Zhang, Wubing
Jeon, Hyun Soo https://orcid.org/0000-0001-8388-2480
Kang, Minji https://orcid.org/0000-0003-0009-4249
Gentles, Andrew J. https://orcid.org/0000-0002-0941-9858
Newman, Aaron M. https://orcid.org/0000-0002-1857-8172
-
Funding
Funding for this research was provided by:
American Association for Cancer Research (19-40-12-STEE)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R21CA238971, R00CA187192, R01CA255450)
Virginia and D.K. Ludwig Fund for Cancer Research
- License Information
-
More Information
Article History
Received: 15 May 2022
Accepted: 25 January 2023
First Online: 6 March 2023
Competing interests
: A.M.N. has patent filings related to expression deconvolution, digital cytometry and cancer biomarkers and has served as a consultant for CiberMed and LiquidCell Dx. A.J.G. has patent filings related to cancer biomarkers and has served as a consultant for CiberMed. No potential conflicts of interest were disclosed by the other authors.
